Skip to main content
. 2013 Mar 22;8(3):e59121. doi: 10.1371/journal.pone.0059121

Table 3. Hazard ratios and 95% confidence intervals for men and women calculated by Cox regression.

Event SUA Model 1 Model 2 Model 3 Model 4
Primary outcome event, men Q1 1 (ref) 1 (ref) 1 (ref) 1 (ref)
Q2 0.87 (0.70–1.08) 0.85 (0.69–1.06) 0.81 (0.65–1.01) 0.84 (0.67–1.05)
Q3 0.99 (0.80–1.22) 0.96 (0.78–1.19) 0.88 (0.71–1.09) 0.90 (0.72–1.11)
Q4 1.22 (1.00–1.50) 1.19 (0.97–1.46) 0.95 (0.76–1.17) 0.96 (0.77–1.20)
Primary outcome event, women Q1 1 (ref) 1 (ref) 1 (ref) 1 (ref)
Q2 0.80 (0.58–1.10) 0.78 (0.56–1.08) 0.71 (0.510.98) 0.73 (0.52–1.01)
Q3 0.95 (0.70–1.30) 0.93 (0.68–1.27) 0.78 (0.56–1.07) 0.76 (0.54–1.05)
Q4 1.59 (1.20–2.10) 1.49 (1.12–1.97) 1.03 (0.75–1.39) 0.99 (0.72–1.36)
Cardiovascular death, men Q1 1 (ref) 1 (ref) 1 (ref) 1 (ref)
Q2 1.12 (0.79–1.59) 1.09 (0.77–1.54) 1.01 (0.71–1.43) 1.01 (0.71–1.44)
Q3 1.36 (0.97–1.90) 1.30 (0.93–1.83) 1.13 (0.81–1.59) 1.13 (0.79–1.60)
Q4 1.88 (1.37–2.58) 1.81 (1.32–2.49) 1.28 (0.92–1.79) 1.26 (0.89–1.78)
Cardiovascular death, women Q1 1 (ref) 1 (ref) 1 (ref) 1 (ref)
Q2 0.55 (0.31–0.99) 0.54 (0.30–0.97) 0.48 (0.26–0.86) 0.51 (0.28–0.92)
Q3 0.94 (0.57–1.56) 0.92 (0.55–1.52) 0.74 (0.44–1.24) 0.73 (0.43–1.24)
Q4 2.11 (1.37–3.24) 1.97 (1.28–3.03) 1.28 (0.80–2.04) 1.31 (0.80–2.13)

Cut off points for quartiles: see Table 2. Ref = reference. Hazard ratios (95% confidence intervals). Primary outcome event = AMI, stroke, resuscitation after cardiac arrest or cardiovascular death.

*

Hazard ratios with p-values less than 0.05 are written in bold letters.

Model 1: uric acid.

Model 2: model 1+ age.

Model 3: model 2+ baseline serum creatinine and diuretics use.

Model 4: model 3+ baseline values of cholesterol, HDL-C, LDL-C, BMI, glucose, triglyceride, history of only diabetes/both diabetes and cardiovascular disease/only cardiovascular disease, history of congestive heart failure, systolic blood pressure, diastolic blood pressure, waist-hip ratio, tobacco use, alcohol use, beta-blocker use, statin use, aspirin use and sibutramine use.